Correct Answer: C. Sickle cell anemia
The clinical presentation of acute, severe, self-limited pain in the small bones of hands and feet in a 10-year-old child is pathognomonic for dactylitis or "hand-foot syndrome," the hallmark of sickle cell anemia. This occurs due to vaso-occlusive crises (VOC) triggered by sickling of red blood cells in the microvasculature of the small bones, leading to ischemia, infarction, and acute pain. The episodes are self-resolving because the sickling is reversible when oxygen tension normalizes. In India, sickle cell disease is endemic in tribal populations (Odisha, Chhattisgarh, Madhya Pradesh, Jharkhand) and affects approximately 2–3% of the population in these regions. Dactylitis typically begins between 6 months and 2 years of age and is one of the earliest clinical manifestations of sickle cell disease, often preceding other complications. The recurrent nature over 1 year, combined with the age and the specific anatomical distribution of pain, makes sickle cell anemia the only diagnosis that fits this presentation. Diagnosis is confirmed by hemoglobin electrophoresis showing HbS, and management involves hydroxyurea, folic acid supplementation, and prophylactic penicillin as per Indian guidelines.
Why the other options are wrong
A. Beta-thalassemia — Beta-thalassemia presents with chronic hemolytic anemia, hepatosplenomegaly, and bone deformities (frontal bossing, maxillary prominence) due to extramedullary hematopoiesis, NOT acute episodic pain in fingers and toes. Dactylitis is not a feature of thalassemia. The pain pattern described is acute and self-resolving, which is incompatible with the chronic, progressive nature of thalassemia complications. B. Alpha-thalassemia — Alpha-thalassemia (including HbH disease) causes chronic hemolytic anemia and splenomegaly but does NOT present with acute vaso-occlusive crises or dactylitis. The episodic acute pain in small bones is not a recognized feature. Alpha-thalassemia lacks the polymerization of deoxygenated hemoglobin that causes sickling and vaso-occlusion. D. Von Willebrand disease type 1 — Von Willebrand disease is a bleeding disorder characterized by mucosal bleeding, epistaxis, and prolonged bleeding time—not acute pain crises in bones. It does not cause vaso-occlusive phenomena or dactylitis. The clinical presentation of recurrent acute pain in fingers and toes is entirely inconsistent with a primary hemostatic defect.
High-Yield Facts
- Dactylitis (hand-foot syndrome) is the earliest clinical manifestation of sickle cell disease, typically appearing between 6 months and 2 years of age.
- Vaso-occlusive crises in sickle cell disease are triggered by hypoxia, dehydration, infection, and cold exposure, causing acute ischemic pain in bones and organs.
- Hemoglobin electrophoresis showing HbS (>80%) is the gold standard diagnostic test for sickle cell anemia in India.
- Hydroxyurea is the disease-modifying agent that increases HbF production, reducing sickling and vaso-occlusive episodes in sickle cell disease.
- Sickle cell disease is endemic in tribal populations of central and eastern India (Odisha, Chhattisgarh, Madhya Pradesh), affecting 2–3% of the population in these regions.
Mnemonics
HAND-FOOT = Sickle Cell Acute pain in HAND and FOOT in a child = think Sickle Cell dactylitis first. This is the earliest VOC manifestation and a classic NEET PG trigger. VOC Triggers: CHIC Cold, Hypoxia, Infection, Crying/stress trigger vaso-occlusive crises in sickle cell disease. Remember these to counsel patients on prevention.
NBE Trap
NBE often pairs thalassemia with sickle cell disease to test whether students confuse chronic hemolytic anemia (thalassemia) with acute vaso-occlusive crises (sickle cell). The key discriminator is the acute, episodic, self-resolving pain pattern—unique to sickling.
Clinical Pearl
In Indian tribal populations, dactylitis in a child presenting with acute finger and toe pain should trigger immediate sickle cell screening via hemoglobin electrophoresis. Early diagnosis and hydroxyurea initiation can prevent life-threatening complications like acute chest syndrome and stroke, which are major causes of morbidity in Indian sickle cell cohorts.
_Reference: Robbins Ch. 14 (Hemolytic Anemias); Harrison Ch. 104 (Sickle Cell Disease); OP Ghai Ch. 9 (Hematologic Disorders in Children)_